4SZ-11764-76359
3 vaccinations
12 coded responses
28 check-ins
12 free-text entries
2 call cases
- Sex
- Female
- Age at first dose
- 61-65
- ZIP prefix
- 902 / CA
- Registered
- 2021-03-27
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-03-24
Dose 1 — Pfizer-BioNTech
-
2021-03-27
Registered in v-safe
-
2021-03-27
Survey response — days 1–6 daily, dose 1MedDRA: Injection site bruising, Injection site pain, Injection site pruritus — Feeling: GoodFree text: Pain and mild bruising at injection site first two days, itching at injection site third dayMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-03-28
- 2021-03-30
- 2021-03-31
- 2021-04-07
-
2021-04-14
Dose 2 — Pfizer-BioNTech
-
2021-04-14
Survey response — day 0, dose 2MedDRA: Unevaluable event — Feeling: Good · Site: PainFree text: Was vaccinated about four hours ago no symptoms of significance yetMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-04-15
Survey response — days 1–6 daily, dose 2MedDRA: Muscle spasms — Feeling: Fair · Site: Pain · Chills · Be unable to do your normal daily activitiesFree text: Leg cramps - severeMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-04-16
-
2021-04-19
Survey response — days 1–6 daily, dose 2MedDRA: Injection site warmth, Temperature intolerance — Feeling: Good · Site: Redness, Itching · Fatigue or tirednessFree text: Heat sensitivity when exposed to sun, at/near injection site even through long sleeve.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-04-20
Survey response — days 1–6 daily, dose 2MedDRA: Fatigue, Headache — Feeling: Fair · Site: Redness, Itching · Fever · Chills, Headache, Fatigue or tirednessFree text: Mild headache and general fatigueMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-04-21
- 2021-05-01
- 2021-05-09
- 2021-05-17
- 2021-07-15
- 2021-10-13
-
2021-12-03
Dose 3 — Pfizer-BioNTech
-
2021-12-05
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Site: Pain, Itching · Chills, Headache · Be unable to do your normal daily activitiesAdult check-in
-
2021-12-07
Health check-in — days 1–6 daily, dose 3Feeling: Good · Site: Pain · Rash, not including the immediate area around the injection siteAdult check-in
-
2021-12-09
Health check-in — days 1–6 daily, dose 3Feeling: Good · Site: Pain · Rash, not including the immediate area around the injection siteAdult check-in
-
2021-12-10
Survey response — day 7, dose 3MedDRA: Injection site reaction, Temperature intolerance — Feeling: Good · Site: ItchingFree text: Heat Sensitivity at injection siteMedDRA releases: 2024-11 · check-in free text available
-
2021-12-17
Survey response — day 14, dose 3MedDRA: Lymph node pain, Lymphadenopathy — Feeling: GoodFree text: Swollen lymph gland on right side of neck. Two bean size nodes swollen. Started last Saturday and are gradually diminishing in size. At first noticeable with slight pain. Now no pain and one is size of small pea other small bean.MedDRA releases: 2024-11 · check-in free text available
-
2021-12-25
Survey response — day 21, dose 3MedDRA: Lymphadenopathy, Rash, Skin laceration — Feeling: GoodFree text: Rash on legs and slightly swollen lymph gland on neck opposite side of injected arm. Scalp woundsMedDRA releases: 2024-11 · check-in free text available
- 2022-01-01
-
2022-01-09
Survey response — day 35, dose 3MedDRA: Skin lesion — Feeling: GoodFree text: Scalp lesionsMedDRA releases: 2024-11 · check-in free text available
-
2022-01-15
Survey response — day 42, dose 3MedDRA: Impaired healing, Skin exfoliation, Skin lesion — Feeling: GoodFree text: Scalp lesions that scale and don't heal. At base of hairline.MedDRA releases: 2024-11 · check-in free text available
-
2022-03-06
Survey response — 3 months, dose 3MedDRA: Medical counselling, Self-medication, Subcutaneous abscess — Feeling: Good · Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: Symptoms: Still suffering Scalp lesions from booster dose , though somewhat fewer. Still treating with Aquaphor ointment and antihistamines. Some improvement but not healed yet. · Healthcare visit (other): Pharmacist consultation. Took one look and said "Ah, Moderna." To rho h i replied "Actually it was Pfizer." This makes me hope a better mom MRNA Vaccine will become available.MedDRA releases: 2024-11 · check-in free text available
-
2022-03-06
Report sent to call center — 3 months, dose 3Get care from a doctor or other healthcare professionalOutpatient clinic or urgent care clinic visit · 1 call case(s)
- 2022-03-08
-
2022-06-05
Survey response — 6 months, dose 3MedDRA: Pruritus, Skin discolouration, Skin lesion — Feeling: Good · Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationFree text: Continue to battle scalp lesions and skin discoloration which were reaction to second dose. They had nearly cleared and came back with a vengeance spreading far beyond the original ones, causing severe itchiness, skin discoloration. No mRNA boost nowMedDRA releases: 2024-11 · check-in free text available
-
2022-06-05
Report sent to call center — 6 months, dose 3Get care from a doctor or other healthcare professionalTelehealth, virtual health, or email health consultation · 1 call case(s)
-
2022-06-06
Call successfulReported to VAERS voluntarily prior to GDIT contact
-
2022-06-06
Call successfulReported to VAERS voluntarily prior to GDIT contact
- 2022-12-05
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-03-24 | Pfizer-BioNTech | |
| 2 | 2021-04-14 | Pfizer-BioNTech | |
| 3 | 2021-12-03 | Pfizer-BioNTech | No |
Call center
2 call center cases
2 successful
VAERS report filed, before or during a call: 2
Free text
Release 6 — days 1–6 daily, dose 1
Systemic reaction (other): Pain and mild bruising at injection site first two days, itching at injection site third day
Release 7 — day 0, dose 2
Systemic reaction (other): Was vaccinated about four hours ago no symptoms of significance yet
Release 7 — days 1–6 daily, dose 2
Systemic reaction (other): Leg cramps - severe
Systemic reaction (other): Heat sensitivity when exposed to sun, at/near injection site even through long sleeve.
Systemic reaction (other): Mild headache and general fatigue
Release 10 — day 7, dose 3
Systemic reaction (other): Heat Sensitivity at injection site
Release 10 — day 14, dose 3
Symptoms: Swollen lymph gland on right side of neck. Two bean size nodes swollen. Started last Saturday and are gradually diminishing in size. At first noticeable with slight pain. Now no pain and one is size of small pea other small bean.
Release 10 — day 21, dose 3
Symptoms: Rash on legs and slightly swollen lymph gland on neck opposite side of injected arm. Scalp wounds
Release 10 — day 35, dose 3
Symptoms: Scalp lesions
Release 10 — day 42, dose 3
Symptoms: Scalp lesions that scale and don't heal. At base of hairline.
Release 11 — 3 months, dose 3
Symptoms: Still suffering Scalp lesions from booster dose , though somewhat fewer. Still treating with Aquaphor ointment and antihistamines. Some improvement but not healed yet.
Healthcare visit (other): Pharmacist consultation. Took one look and said "Ah, Moderna." To rho h i replied "Actually it was Pfizer." This makes me hope a better mom MRNA Vaccine will become available.
Release 11 — 6 months, dose 3
Symptoms: Continue to battle scalp lesions and skin discoloration which were reaction to second dose. They had nearly cleared and came back with a vengeance spreading far beyond the original ones, causing severe itchiness, skin discoloration. No mRNA boost now cut off by CDC
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| HCVO | Medical counselling | · | · | ✓ |
| SD | Impaired healing | · | · | ✓ |
| SD | Lymph node pain | · | · | ✓ |
| SD | Lymphadenopathy | · | · | ✓ |
| SD | Pruritus | · | · | ✓ |
| SD | Rash | · | · | ✓ |
| SD | Self-medication | · | · | ✓ |
| SD | Skin discolouration | · | · | ✓ |
| SD | Skin exfoliation | · | · | ✓ |
| SD | Skin laceration | · | · | ✓ |
| SD | Skin lesion | · | · | ✓ |
| SD | Subcutaneous abscess | · | · | ✓ |
| SRO | Fatigue | ✓ | ✓ | ✓ |
| SRO | Headache | ✓ | ✓ | ✓ |
| SRO | Injection site bruising | ✓ | ✓ | ✓ |
| SRO | Injection site pain | ✓ | ✓ | ✓ |
| SRO | Injection site pruritus | ✓ | ✓ | ✓ |
| SRO | Injection site reaction | · | · | ✓ |
| SRO | Injection site warmth | ✓ | ✓ | ✓ |
| SRO | Muscle spasms | ✓ | ✓ | ✓ |
| SRO | Temperature intolerance | ✓ | ✓ | ✓ |
| SRO | Unevaluable event | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release